- Home
- BMRN vs RIVN Comparison
BMRN vs RIVN Comparison
Compare BMRN & RIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- RIVN
- Stock Information
- Founded
- BMRN 1996
- RIVN 2009
- Country
- BMRN United States
- RIVN United States
- Employees
- BMRN N/A
- RIVN N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- RIVN Auto Manufacturing
- Sector
- BMRN Health Care
- RIVN Consumer Discretionary
- Exchange
- BMRN Nasdaq
- RIVN Nasdaq
- Market Cap
- BMRN 13.7B
- RIVN 15.0B
- IPO Year
- BMRN 1999
- RIVN 2021
- Fundamental
- Price
- BMRN $59.17
- RIVN $11.60
- Analyst Decision
- BMRN Buy
- RIVN Hold
- Analyst Count
- BMRN 22
- RIVN 21
- Target Price
- BMRN $94.00
- RIVN $13.85
- AVG Volume (30 Days)
- BMRN 2.0M
- RIVN 34.6M
- Earning Date
- BMRN 05-01-2025
- RIVN 05-06-2025
- Dividend Yield
- BMRN N/A
- RIVN N/A
- EPS Growth
- BMRN 153.71
- RIVN N/A
- EPS
- BMRN 2.21
- RIVN N/A
- Revenue
- BMRN $2,853,915,000.00
- RIVN $4,970,000,000.00
- Revenue This Year
- BMRN $12.23
- RIVN $12.96
- Revenue Next Year
- BMRN $9.93
- RIVN $38.21
- P/E Ratio
- BMRN $26.81
- RIVN N/A
- Revenue Growth
- BMRN 17.97
- RIVN 12.09
- 52 Week Low
- BMRN $52.93
- RIVN $8.32
- 52 Week High
- BMRN $94.85
- RIVN $18.86
- Technical
- Relative Strength Index (RSI)
- BMRN 37.64
- RIVN 48.35
- Support Level
- BMRN $52.93
- RIVN $11.17
- Resistance Level
- BMRN $60.93
- RIVN $12.15
- Average True Range (ATR)
- BMRN 3.18
- RIVN 0.92
- MACD
- BMRN -0.53
- RIVN -0.01
- Stochastic Oscillator
- BMRN 34.01
- RIVN 39.62
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About RIVN Rivian Automotive Inc.
Rivian Automotive Inc is an automotive manufacturer that develops and builds electric vehicles ("EVs") as well as software and services. It launches its consumer vehicle business with the R1 platform consisting of two vehicles: the R1T, and the R1S. The company has two reportable segments: Automotive, which derives the majority of revenue, and Software and Services segment. The Automotive reportable segment derives its revenues and cost of revenues from the production and sale of new EVs and the sale of regulatory credits generated by the production and sale of EVs. The Software and services reportable segment derives its revenues and cost of revenues primarily from remarketing, vehicle repair and maintenance services, and vehicle electrical architecture and software development services.